Ratnakar Securities Pvt. Ltd.

TRANSGENE BIOTEK LTD.

NSE : NABSE : 526139ISIN CODE : INE773D01018Industry : Hospital & Healthcare ServicesHouse : Private

BSE7.490.16 (+2.18 %)

PREV CLOSE ( ) 7.33

OPEN PRICE ( ) 7.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 6992

TODAY'S LOW / HIGH ( )7.16 7.90

52 WK LOW / HIGH ( ) 5.7912.46

Quarters

Select year

( in Million)

Particulars

Sep 2024

Jun 2024

Mar 2024

Dec 2023

Audited / UnAudited

Audited

UnAudited

Net Sales

0.58

0.49

0.45

Total Expenditure

1.35

4.61

3.13

1.53

PBIDT (Excl OI)

-0.77

-4.12

-2.68

-1.08

Other Income

0.44

6.52

0.51

0.44

Operating Profit

-0.33

2.4

-2.17

-0.64

Interest

0.17

0.32

Exceptional Items

PBDT

-0.5

2.23

-2.49

-0.96

Depreciation

0.23

Profit Before Tax

-0.73

-2.72

-1.19

Tax

Provisions and contingencies

Profit After Tax

-0.73

-2.72

-1.19

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

-0.73

-2.72

-1.19

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

-0.73

1.99

-2.72

-1.19

Equity Capital

757.7

Face Value (IN RS)

Reserves

Calculated EPS

-0.00

0.02

-0.03

-0.01

Calculated EPS (Annualised)

-0.03

0.10

-0.14

-0.06

No of Public Share Holdings

53072098

% of Public Share Holdings

76.36

PBIDTM% (Excl OI)

-132.75

-840.81

-595.55

-240

PBIDTM%

-56.89

489.79

-482.22

-142.22

PBDTM%

-86.20

455.10

-553.33

-213.33

PBTM%

-125.86

408.16

-604.44

-264.44

PATM%

-125.86

408.16

-604.44

-264.44

Notes

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Quarterly Results

TRANSGENE BIOTEK LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES